| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 01/14/2004 | EP1379515A1 Lipid lowering biphenylcarboxamides |
| 01/14/2004 | EP1379495A2 Ligands of the alpha-v-beta 6 integrin |
| 01/14/2004 | EP1379283A2 Identification of target-specific folding sites in peptides and proteins |
| 01/14/2004 | EP1379131A1 Regulation of weight |
| 01/14/2004 | CN1134264C Antithrombotic agents |
| 01/14/2004 | CN1134225C Novel sweetener compositions |
| 01/14/2004 | CN1134224C Mixed crystals comprising Aspartame and Aspartame derivative and process for producing same |
| 01/13/2004 | US6677429 Echinocandin derivatives, preparation method and application as anti-fungal agents |
| 01/13/2004 | US6677367 Lysine derivative with 2-aminosulfonylthiophene substituent; acquired immunodeficiency syndrome (aids) viricides |
| 01/13/2004 | US6676941 For inhibiting angiogenesis and induce tumor regression; cancer therapy |
| 01/08/2004 | WO2004003561A1 Peptide rod amphiphiles and self-assembly of same |
| 01/08/2004 | WO2004003012A2 Novel variants of the papm polypeptide of bacteria of genus streptomyces |
| 01/08/2004 | WO2004003005A2 Sh2 domain binding inhibitors |
| 01/08/2004 | WO2004002985A1 Peptidic thrombin inhibitor compound |
| 01/08/2004 | WO2004002509A2 Use of casein peptides for treating hypertension |
| 01/08/2004 | WO2004002418A2 Compositions and methods comprising protein activated receptor antagonists |
| 01/08/2004 | WO2002062372A3 Tripeptide derivatives for the treatment of postlesional diseases of the nervous system |
| 01/08/2004 | WO2002053594A3 Inhibitors of memapsin 2 and use thereof |
| 01/08/2004 | US20040006247 Reacting isobutylene, ethylene and mineral acid; hydrolyzing the ester to produce 3,3-dimethylbutanol; and converting 3,3-dimethylbutanol to 3,3-dimethylbutanal |
| 01/08/2004 | US20040006230 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| 01/08/2004 | US20040006132 For therapy |
| 01/08/2004 | US20040006067 Substituted piperidines and methods of use |
| 01/08/2004 | US20040006063 Dipeptide derivatives |
| 01/08/2004 | US20040006049 For therapy of prostatitis, benign prostate hyperplasia or prostate cancer |
| 01/08/2004 | US20040006022 For therapy of autoimmune or an inflammatory disease |
| 01/08/2004 | US20040006013 Linear and cyclic peptide and pseudopeptide compounds useful as analgesics, pharmaceutical compositions comprising such compounds, the use of the compounds and the compositions in the treatment of pain, and commercial packages containing such |
| 01/08/2004 | US20040005650 Identifying enzyme modulators for treating neurodegenerative, autoimmune and tumor diseases |
| 01/08/2004 | US20040005632 Use of "tethering"; compounds can be in the form of an individual enantiomer, diasteromer, geometric isomer, or mixtures thereof; for drug discovery |
| 01/08/2004 | DE10224844A1 Nicht-peptidische BRS-3-Agonisten Non-peptidic BRS-3 agonist |
| 01/08/2004 | CA2490282A1 Use of casein peptides for treating hypertension |
| 01/08/2004 | CA2490256A1 Novel variants of the papm polypeptide of bacteria of genus streptomyces |
| 01/08/2004 | CA2490129A1 Compositions and methods comprising protein activated receptor antagonists |
| 01/07/2004 | EP1378573A1 Interleukin 1 beta protease and interleukin 1 beta protease inhibitors |
| 01/07/2004 | EP1378522A2 Methods of enhancing bioactivity of chemokines |
| 01/07/2004 | EP1377601A2 Type b botulism toxin inhibitors |
| 01/07/2004 | EP1377542A1 Hiv protease inhibitors based on amino acid derivatives |
| 01/07/2004 | EP0600880B1 Interleukin 1- beta protease and interleukin 1-beta protease inhibitors |
| 01/07/2004 | CN1466576A Quinolne-(C=O)-CD1, tri-and tetrapeptide) derivatives as caspase inhibitors |
| 01/07/2004 | CN1133649C Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease |
| 01/07/2004 | CN1133648C Substituted phenylalamine type compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 01/07/2004 | CN1133647C Heterocyclic compound used as leucocyte adherence inhibitor and VLA-4 antagonist |
| 01/07/2004 | CN1133437C Nocathiacin antibiotics |
| 01/06/2004 | US6673929 Process for preparing growth hormone secretagogues |
| 01/06/2004 | US6673822 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 01/06/2004 | US6673771 Administering inhibitor of tumor necrosis factor related activator induced cytokine/receptor activator of nuclear factor kappa beta ligand, peptide having cyclic portion and exocyclic portions comprising tyrosine or phenylalanine |
| 01/02/2004 | EP1375664A1 Method for the sectetion and production of protein |
| 01/02/2004 | EP1375639A1 Selection media for beauveriolide i or beauveriolide iii and process for selectively producing these substances |
| 01/02/2004 | EP1375513A1 Immunopotentiators |
| 01/02/2004 | EP1374907A2 Drug transport and delivery system |
| 01/02/2004 | EP1374885A1 Use of at least one peptide of alpha-s2 casein with inhibiting activity of ACE for the preparation of medicaments and foodstuffs |
| 01/02/2004 | EP1373303A1 Novel peptide ligands of leukocyte integrins |
| 01/02/2004 | EP1373187A1 Novel aspartame powders |
| 01/02/2004 | EP1372732A1 Enzyme-activated cytostatic conjugates with integrin ligands |
| 01/02/2004 | EP1372718A2 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 01/02/2004 | EP1372692A2 Asymmetric synthesis of (s, s, r)-(-)-actinonin and its analogs and uses therefor |
| 01/02/2004 | EP1372620A2 Methods for restoring cognitive function following systemic stress |
| 01/01/2004 | US20040003418 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer |
| 01/01/2004 | US20040002487 Bone disorders; osteoporosis; oral diseases; antiarthritic agents |
| 01/01/2004 | US20040002479 Proteasome inhibitors; bone disorders |
| 01/01/2004 | US20040002448 Viricides; induction immunology response |
| 01/01/2004 | US20040002441 Antitumor agents; anticancer agents; bactericides; polymerase chain reactions |
| 01/01/2004 | US20040002117 Immunosuppressive agents of given formula; prevents dephosphorylation |
| 01/01/2004 | US20040002113 Detection and treatment methods for type I diabetes |
| 12/31/2003 | WO2004000874A1 Process for the production of lisinopril |
| 12/31/2003 | WO2004000365A1 Drug transport and delivery system |
| 12/31/2003 | WO2003087137A3 New therapeutic uses of tri-, tetra-, penta-, and polypeptides |
| 12/31/2003 | WO2003087070A3 Growth hormone secretagogues |
| 12/31/2003 | WO2003066814A3 Peptide-dependent upregulation of telomerase expression |
| 12/31/2003 | WO2003006492A3 Biologically active peptides |
| 12/31/2003 | WO2002092774A3 Replicase cycling reaction amplification |
| 12/31/2003 | CN1464881A New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents |
| 12/31/2003 | CA2490354A1 Drug transport and delivery system |
| 12/30/2003 | US6670393 Carbamate-based cationic lipids |
| 12/30/2003 | US6670332 Cytofectins comprising complex amphiphilic lipids in which a bioactive agent which is recognized by biological systems is joined to a Rosenthal Inhibitor core structure through an alkyl linking group |
| 12/30/2003 | US6670326 Depsipeptide compound |
| 12/30/2003 | US6670324 Cyclic peptide antifungal agents |
| 12/30/2003 | US6670157 Polypeptides involved in the biosynthesis of streptogramins, nucleotide sequences coding for these polypeptides and their use |
| 12/30/2003 | CA2140927C Platelet aggregation inhibitors |
| 12/25/2003 | US20030236402 A caspase-3 enzyme inhibitors, 3-(3-alkyl-amino-2-oxo-1,2-dihydro-1-pyrazinyl-alkanoylamino) -4-oxopentanoic acid; treating cardiac or cerebral ischemia or reperfusion injury, diabetes, AIDS |
| 12/25/2003 | US20030236272 Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states |
| 12/25/2003 | US20030236242 Viricides |
| 12/25/2003 | US20030236197 Modulators of beta-amyloid peptide aggregation |
| 12/25/2003 | US20030235873 Process for detecting enzyme activity in an immunoassay |
| 12/24/2003 | WO2003107004A2 Method for isolating an allosteric effector of a receptor |
| 12/24/2003 | WO2003106482A1 Peptides derivatives comprising thiazepine group for the treatment of hyperlipidemic conditions |
| 12/24/2003 | WO2003106481A1 A process of producing ala-glu dipeptide |
| 12/24/2003 | WO2003106480A1 Antibacterial amide macrocycles |
| 12/24/2003 | WO2003106431A2 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same |
| 12/24/2003 | WO2003106405A1 Aspartyl protease inhibitors |
| 12/24/2003 | WO2003105835A1 Methods of use for tripeptidyl peptidase ii inhibitors as anticancer agents |
| 12/24/2003 | WO2003045981A3 Concentrating aqueous fractions of lisinopril by reverse osmosis |
| 12/24/2003 | WO2003040174A3 Substituted amino ketone compounds |
| 12/24/2003 | WO2003039454A3 Beta-secretase inhibitors and methods of use |
| 12/24/2003 | WO2002046147A3 Perturbed membrane-binding compounds |
| 12/24/2003 | CN1463270A Disulfide prodrugs and linkers and stablizers useful therefore |
| 12/24/2003 | CA2489463A1 Peptides derivatives comprising thiazepine group for the treatment of hyperlipidemic conditions |
| 12/24/2003 | CA2489454A1 Antibacterial amide macrocycles |
| 12/24/2003 | CA2489447A1 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same |
| 12/24/2003 | CA2489389A1 Method for isolating an allosteric effector of a receptor |
| 12/24/2003 | CA2489095A1 Aspartyl protease inhibitors |